论文部分内容阅读
采用MTT法，对实体瘤体外药物敏感性进行研究，选用米托蒽醌等8种抗癌药物，进行对照试验。共研究42例，18例（42．86％）对米托蒽高醌度敏感。其中肺癌33％（2／6），食道癌50％（5／10），胃癌33％（6／8），肠癌50％（3／6），2例淋巴瘤均敏感。认为，米托蒽醌有体外高效、广谱的抗癌作用。
The MTT method was used to study the drug sensitivity of solid tumors in vitro. Eight kinds of anticancer drugs, such as mitoxantrone, were selected for control experiments. A total of 42 cases were studied, and 18 cases (42.86%) were sensitive to mitoxantrone. Among them, 33% (2/6) of lung cancer, 50% (5/10) of esophageal cancer, 33% (6/8) of gastric cancer, 50% (3/6) of colorectal cancer and 2 lymphoma were all sensitive. That mitoxantrone has an in vitro efficient, broad-spectrum anti-cancer effect.